Table 1 Characteristics of participants included in the analysis.
From: Comparative analysis of adaptive immunity to SARS-CoV-2 in infected children and adults
Characteristics | Number (%) of children (n = 28) | Number (%) of adults (n = 28) |
|---|---|---|
Age (years) | ||
Median [Min, Max] | 10 [3, 17] | 42 [19, 62] |
Sex | ||
Male | 14 (50) | 14 (50) |
Female | 14 (50) | 14 (50) |
Race or ethnicity | ||
White | 15 (54) | 17 (61) |
Middle Eastern | 3 (11) | 3 (11) |
Asian | 8 (29) | 8 (29) |
Undisclosed | 2 (7) | 0 (0) |
Primary SARS-CoV-2 infection | ||
Asymptomatic—WHO Score 1 | 4 (14) | 0 (0) |
Symptomatic (mild)—WHO Score 2–3 | 24 (86) | 28 (100) |
Severe/hospitalized—WHO Score 4–5 | 0 (0) | 0 (0) |
Presumed strain based on infection period | ||
Ancestral (Wuhan-1 like) | 12 (43) | 28 (100) |
Alpha variant | 16 (57) | 0 (0) |
Time since infection at analysis (months) | ||
Mean (SD) | 7.4 (2.8) | 7.0 (2.5) |
Median [Min, Max] | 7.3 [2.7, 15.4] | 7.2 [2.7, 15.4] |
Serology status at analysisa | ||
Seronegative | 2 (7) | 1 (4) |
Asymptomatic | 1 (4) | 0 (0) |
Symptomatic | 1 (4) | 1 (4) |
Seropositive | 26 (93) | 27 (96) |
Asymptomatic | 3 (11) | 0 (0) |
Symptomatic | 23 (82) | 26 (93) |
